Could short thyroid hormone withdrawal be an effective strategy for radioiodine remnant ablation in differentiated thyroid cancer patients?
A Piccardo, M Puntoni, G Ferrarazzo, L Foppiani… - European journal of …, 2018 - Springer
Purpose Current guidelines recommend thyroid hormone withdrawal (THW) of 3–4 weeks
before radioiodine remnant ablation (RRA) of differentiated thyroid carcinoma (DTC). We …
before radioiodine remnant ablation (RRA) of differentiated thyroid carcinoma (DTC). We …
Postoperative Thyroglobulin and Neck Ultrasound in the Risk Restratification and Decision to Perform 131I Ablation
Context: There is much debate surrounding the choice of which patient should be submitted
to postsurgical remnant radioiodine remnant ablation (RRA), particularly in low-risk (LR) and …
to postsurgical remnant radioiodine remnant ablation (RRA), particularly in low-risk (LR) and …
Radioiodine thyroid remnant ablation in patients with differentiated thyroid carcinoma (DTC): prospective comparison of long-term outcomes of treatment with 30, 60 …
A Kukulska, J Krajewska, M Gawkowska-Suwińska… - Thyroid research, 2010 - Springer
Background The aim of this study is to compare the effectiveness of 131 I therapy between
three groups of DTC patients who received 30, 60 or 100 mCi for thyroid remnant ablation …
three groups of DTC patients who received 30, 60 or 100 mCi for thyroid remnant ablation …
Impact factors of benefiting from initial 131I ablation in patients with intermediate-risk differentiated thyroid carcinoma: a study based on a re-evaluation of therapeutic …
L Ren, Y Hu, Y Hu, D Xiao, J Sun, B Zhu… - Nuclear Medicine …, 2024 - journals.lww.com
Objective This study was carried out to confirm whether patients with intermediate-risk
differentiated thyroid cancer (DTC) could benefit from initial 131 I ablation and to identify the …
differentiated thyroid cancer (DTC) could benefit from initial 131 I ablation and to identify the …
Prospective study confirms that radioiodine remnant ablation is not necessary in low-risk differentiated thyroid cancer
F Pacini - European Thyroid Journal, 2016 - etj.bioscientifica.com
Department of Medical, Surgical and Neurological Sciences, University of Siena, Siena, Italy
patients with different risk of recurrence [5]. The benefits of postoperative 131I differs …
patients with different risk of recurrence [5]. The benefits of postoperative 131I differs …
Assessment of Different Radioactive Iodine Ablation Strategies in Intermediate and High Risk Papillary Thyroid Cancer
HA El-Hadaad, MF Akl, AEMM Youssef… - … Egyptian Journal of …, 2022 - ejhm.journals.ekb.eg
Background: Papillary thyroid cancer (PTC) represents most of cases of differentiated thyroid
cancers. Thyroidectomy followed by radioactive iodine (RAI) remnant ablation represent the …
cancers. Thyroidectomy followed by radioactive iodine (RAI) remnant ablation represent the …
[HTML][HTML] Factors affecting ablation success after I-131 radioactive iodine therapy in low and intermediate risk papillary thyroid cancer
S Goksel, U Avci - Hormone and Metabolic Research, 2023 - thieme-connect.com
The study was to evaluate the effect of radioactive iodine (RAI) treatment application time
and clinical, histopathological factors on ablation success in patients with operated papillary …
and clinical, histopathological factors on ablation success in patients with operated papillary …
Post-Surgical Ablative or Adjuvant Radioiodine Therapy Has No Impact on Outcome in 1–4 cm Differentiated Thyroid Cancers without Extrathyroidal Extension
S De Leo, M Trevisan, C Colombo, G Gazzano… - Journal of Clinical …, 2021 - mdpi.com
Whether to conduct remnant ablation or adjuvant radioactive iodine (RAI) therapy in patients
with intrathyroidal differentiated thyroid carcinoma (DTC), sized 1.1–4 cm, is debated. We …
with intrathyroidal differentiated thyroid carcinoma (DTC), sized 1.1–4 cm, is debated. We …
Delaying radioactive iodine ablation for up to one year does not increase recurrence for patients with differentiated thyroid cancer
MJ Livhits, MW Yeh - Clinical Thyroidology, 2016 - liebertpub.com
Background Patients with differentiated thyroid cancer (DTC) who undergo total
thyroidectomy are candidates for adjuvant radioactive iodine ablation (RAI). RAI is used to …
thyroidectomy are candidates for adjuvant radioactive iodine ablation (RAI). RAI is used to …
Postoperative radioiodine ablation in patients with low risk differentiated thyroid carcinoma
JJ Díez, E Grande, P Iglesias - Medicina Clínica (English Edition), 2015 - Elsevier
Most patients with newly diagnosed differentiated thyroid carcinoma have tumours with low
risk of mortality and recurrence. Standard therapy has been total or near total thyroidectomy …
risk of mortality and recurrence. Standard therapy has been total or near total thyroidectomy …